JP2019530673A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019530673A5 JP2019530673A5 JP2019513929A JP2019513929A JP2019530673A5 JP 2019530673 A5 JP2019530673 A5 JP 2019530673A5 JP 2019513929 A JP2019513929 A JP 2019513929A JP 2019513929 A JP2019513929 A JP 2019513929A JP 2019530673 A5 JP2019530673 A5 JP 2019530673A5
- Authority
- JP
- Japan
- Prior art keywords
- composition according
- platelet cells
- composition
- therapeutic agent
- antibody
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023061666A JP7497087B2 (ja) | 2016-09-13 | 2023-04-05 | 治療剤送達のための血小板組成物及び方法 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662393839P | 2016-09-13 | 2016-09-13 | |
| US62/393,839 | 2016-09-13 | ||
| PCT/US2017/051376 WO2018053010A1 (en) | 2016-09-13 | 2017-09-13 | Platelet compositions and methods for the delivery of therapeutic agents |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023061666A Division JP7497087B2 (ja) | 2016-09-13 | 2023-04-05 | 治療剤送達のための血小板組成物及び方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019530673A JP2019530673A (ja) | 2019-10-24 |
| JP2019530673A5 true JP2019530673A5 (enExample) | 2020-10-22 |
| JP7262774B2 JP7262774B2 (ja) | 2023-04-24 |
Family
ID=61620161
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019513929A Active JP7262774B2 (ja) | 2016-09-13 | 2017-09-13 | 治療剤送達のための血小板組成物及び方法 |
| JP2023061666A Active JP7497087B2 (ja) | 2016-09-13 | 2023-04-05 | 治療剤送達のための血小板組成物及び方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023061666A Active JP7497087B2 (ja) | 2016-09-13 | 2023-04-05 | 治療剤送達のための血小板組成物及び方法 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US11730765B2 (enExample) |
| EP (1) | EP3512554B1 (enExample) |
| JP (2) | JP7262774B2 (enExample) |
| KR (2) | KR102557336B1 (enExample) |
| CN (1) | CN109890420B (enExample) |
| AU (1) | AU2017327360A1 (enExample) |
| CA (1) | CA3036693A1 (enExample) |
| WO (1) | WO2018053010A1 (enExample) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20190388407A1 (en) | 2017-02-12 | 2019-12-26 | Aiviva Biopharma, Inc. | Multikinase inhibitors of vegf and tfg beta and uses thereof |
| US11073462B2 (en) | 2017-12-06 | 2021-07-27 | Lightintegra Technology Inc. | Non-activated platelet transfusion methods for enhancement of patient treatment outcomes |
| CA3087344A1 (en) | 2018-01-05 | 2019-07-11 | Platelet Biogenesis, Inc. | Compositions and methods for producing megakaryocytes |
| CN112135639B (zh) * | 2018-04-06 | 2023-10-20 | 北卡罗莱纳州立大学 | 细胞组装介导的癌症免疫治疗检查点抑制剂的递送 |
| JP2021529770A (ja) | 2018-06-29 | 2021-11-04 | プレートレット バイオジェネシス， インコーポレイテッド | 薬物送達のための組成物およびその使用方法 |
| JP2021534153A (ja) | 2018-08-15 | 2021-12-09 | アイビバ バイオファーマ インコーポレイテッド | Ｖｅｇｆおよびｔｇｆベータのマルチキナーゼ阻害剤およびその使用 |
| US20210353679A1 (en) * | 2018-10-10 | 2021-11-18 | North Carolina State University | Pd-l1 presenting platelets reverse new-onset type 1 diabetes |
| CN116322650A (zh) * | 2020-07-01 | 2023-06-23 | 赛络生物医药有限公司 | 血小板膜包被的纳米颗粒及其用途 |
| US20230285559A1 (en) * | 2020-07-23 | 2023-09-14 | The Regents Of The University Of California | Therapeutic hydrogel for the delivery of car-t cells |
| CN112826941A (zh) * | 2020-08-14 | 2021-05-25 | 南京邮电大学 | 一种用于递送蛋白药物的磁性血小板复合物的制备方法 |
| CN112891317A (zh) * | 2021-02-05 | 2021-06-04 | 东南大学 | 一种血小板载药系统的制备方法 |
| US20260226138A1 (en) * | 2022-11-09 | 2026-08-06 | Wisconsin Alumni Research Foundation | Combination tumor therapy with thrombosis initiation and platelet recruitment |
| CN116159149B (zh) * | 2023-02-27 | 2024-11-15 | 上海中医药大学 | 一种基于血小板的免疫连接器的制备方法及应用 |
| CN116603073A (zh) * | 2023-05-29 | 2023-08-18 | 上海臻上医药科技有限公司 | 血小板负载的小分子药物制剂及其制备方法、和用途 |
| CN118806929B (zh) * | 2024-07-13 | 2026-02-06 | 江苏省肿瘤医院 | 一种复合型纳米硅球递药体系及其制备方法和应用 |
Family Cites Families (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB929406A (en) | 1958-12-22 | 1963-06-19 | Upjohn Co | A process for the production of encapsulated material |
| GB929401A (en) | 1958-12-22 | 1963-06-19 | Upjohn Co | Encapsulated emulsions and processes for their preparation |
| GB969808A (en) | 1962-06-08 | 1964-09-16 | Boots Pure Drug Co Ltd | Anthelmintic compositions and compounds |
| GB1413186A (en) | 1973-06-27 | 1975-11-12 | Toyo Jozo Kk | Process for encapsulation of medicaments |
| IT1148784B (it) | 1980-04-09 | 1986-12-03 | Eurand Spa | Procedimento per la preparazione di microcapsule in un veicolo liquido |
| US4794000A (en) | 1987-01-08 | 1988-12-27 | Synthetic Blood Corporation | Coacervate-based oral delivery system for medically useful compositions |
| US5019400A (en) | 1989-05-01 | 1991-05-28 | Enzytech, Inc. | Very low temperature casting of controlled release microspheres |
| US6197346B1 (en) | 1992-04-24 | 2001-03-06 | Brown Universtiy Research Foundation | Bioadhesive microspheres and their use as drug delivery and imaging systems |
| EP0804249A2 (en) | 1994-03-15 | 1997-11-05 | Brown University Research Foundation | Polymeric gene delivery system |
| JPH08109142A (ja) * | 1994-08-16 | 1996-04-30 | S R L:Kk | 血小板薬物送達システム |
| US6143211A (en) | 1995-07-21 | 2000-11-07 | Brown University Foundation | Process for preparing microparticles through phase inversion phenomena |
| US7294455B2 (en) | 2003-05-16 | 2007-11-13 | The University Of North Carolina At Chapel Hill | Fixed-dried platelets cross-linked to protein |
| US20060141482A1 (en) * | 2004-12-23 | 2006-06-29 | Awdalla Essam T | Method and multicomponent conjugates for treating cancer |
| US20080317761A1 (en) * | 2004-04-28 | 2008-12-25 | The Trustees Of The University Of Pennsylvania | Peptide-Mediated Protein Transduction Into Cells of the Hematopoietic Lineage |
| EP3530736A3 (en) * | 2005-05-09 | 2019-11-06 | ONO Pharmaceutical Co., Ltd. | Human monoclonal antibodies to programmed death 1 (pd-1) and methods for treating cancer using anti-pd-1 antibodies alone or in combination with other immunotherapeutics |
| US20070178107A1 (en) * | 2006-01-31 | 2007-08-02 | Awdalla Essam T | Method and means for treating solid tumors |
| US20130129752A1 (en) * | 2006-04-25 | 2013-05-23 | Immune Disease Institute, Inc. | Targeted delivery to leukocytes using protein carriers |
| US8512697B2 (en) * | 2007-05-16 | 2013-08-20 | The University Of North Carolina At Chapel Hill | Delivery of micro- and nanoparticles with blood platelets |
| EP2111869A1 (en) | 2008-04-23 | 2009-10-28 | Stichting Sanquin Bloedvoorziening | Compositions and methods to enhance the immune system |
| WO2010014784A2 (en) | 2008-08-01 | 2010-02-04 | Bristol-Myers Squibb Company | Combination of anti-ctla4 antibody with diverse therapeutic regimens for the synergistic treatment of proliferative diseases |
| MX356367B (es) | 2008-12-09 | 2018-05-25 | Genentech Inc | Anticuerpos anti-pd-l1 y su uso para mejorar la funcion de celulas t. |
| US8673359B2 (en) | 2010-07-08 | 2014-03-18 | Brown University | Nanoparticle compositions and methods for improved oral delivery of active agents |
| US9856320B2 (en) * | 2012-05-15 | 2018-01-02 | Bristol-Myers Squibb Company | Cancer immunotherapy by disrupting PD-1/PD-L1 signaling |
| DE112013006579B4 (de) * | 2013-02-02 | 2024-09-05 | Duke University | Verfahren zum Isolieren zirkulierender Tumorzellen |
| CA2964155A1 (en) * | 2014-10-10 | 2016-04-14 | Idera Pharmaceuticals, Inc. | Treatment of cancer using tlr9 agonist with checkpoint inhibitors |
-
2017
- 2017-09-13 KR KR1020197009451A patent/KR102557336B1/ko active Active
- 2017-09-13 EP EP17851460.0A patent/EP3512554B1/en not_active Not-in-force
- 2017-09-13 KR KR1020237022734A patent/KR20230109771A/ko not_active Ceased
- 2017-09-13 US US16/332,939 patent/US11730765B2/en active Active
- 2017-09-13 JP JP2019513929A patent/JP7262774B2/ja active Active
- 2017-09-13 AU AU2017327360A patent/AU2017327360A1/en not_active Abandoned
- 2017-09-13 CN CN201780066511.5A patent/CN109890420B/zh not_active Expired - Fee Related
- 2017-09-13 WO PCT/US2017/051376 patent/WO2018053010A1/en not_active Ceased
- 2017-09-13 CA CA3036693A patent/CA3036693A1/en active Pending
-
2023
- 2023-04-05 JP JP2023061666A patent/JP7497087B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Bazeed et al. | Pancreatic cancer: challenges and opportunities in locoregional therapies | |
| Wang et al. | Janus gold triangle-mesoporous silica nanoplatforms for hypoxia-activated radio-chemo-photothermal therapy of liver cancer | |
| Duan et al. | Advances and prospects in the treatment of pancreatic cancer | |
| Paciotti et al. | Synthesis and evaluation of paclitaxel-loaded gold nanoparticles for tumor-targeted drug delivery | |
| Sun et al. | Recent advances in photothermal therapy-based multifunctional nanoplatforms for breast cancer | |
| Wang et al. | Toward targeted therapy in chemotherapy-resistant pancreatic cancer with a smart triptolide nanomedicine | |
| Jiang et al. | Metformin and docosahexaenoic acid hybrid micelles for premetastatic niche modulation and tumor metastasis suppression | |
| Crous et al. | Photodynamic therapy of lung cancer, where are we? | |
| Fang et al. | Implantable sandwich-like scaffold/fiber composite spatiotemporally releasing combretastatin A4 and doxorubicin for efficient inhibition of postoperative tumor recurrence | |
| Jeong et al. | Development of highly efficient nanocarrier-mediated delivery approaches for cancer therapy | |
| Miller et al. | Antiangiogenic antitumor activity of HPMA copolymer–paclitaxel–alendronate conjugate on breast cancer bone metastasis mouse model | |
| Dinakaran et al. | The use of nanomaterials in advancing photodynamic therapy (PDT) for deep-seated tumors and synergy with radiotherapy | |
| Lopez et al. | Ultrasound therapy, chemotherapy and their combination for prostate cancer | |
| SG158919A1 (en) | Constructs binding to phosphatidylserine and their use in disease treatment | |
| Daenen et al. | Treatment-induced host-mediated mechanisms reducing the efficacy of antitumor therapies | |
| Baghban et al. | Were magnetic materials useful in cancer therapy? | |
| Singh et al. | The implications and future perspectives of nanomedicine for cancer stem cell targeted therapies | |
| Larsson et al. | Local co-administration of gene-silencing RNA and drugs in cancer therapy: State-of-the art and therapeutic potential | |
| Cohen et al. | A novel intralymphatic nanocarrier delivery system for cisplatin therapy in breast cancer with improved tumor efficacy and lower systemic toxicity in vivo | |
| Timmer et al. | Locally advanced pancreatic cancer: percutaneous management using ablation, brachytherapy, intra-arterial chemotherapy, and intra-tumoral immunotherapy | |
| Maranhão et al. | Advances in non-invasive drug delivery for atherosclerotic heart disease | |
| Huang et al. | Irreversible electroporation-induced inflammation facilitates neutrophil-mediated drug delivery to enhance pancreatic cancer therapy | |
| Liu et al. | Advancing immune checkpoint blockade in colorectal cancer therapy with nanotechnology | |
| Xu et al. | A photoactivatable self-assembled nanoagonist for synergistic therapy against pancreatic ductal adenocarcinoma | |
| Wang et al. | A low molecular weight multifunctional theranostic molecule for the treatment of prostate cancer |